News
An estimated 1.5 million people in the UK take GLP-1 drugs like Mounjaro, Ozempic and Wegovy, either to lose weight or to ...
The company downgraded its guidance for the second time in six weeks as it announced a restructuring plan.
The maker of the popular weight-loss drug Wegovy announced on Wednesday that it will be cutting 9,000 jobs in the company.
According to insiders close to the queen of all media, Oprah has reportedly dropped a whopping 40 pounds — and is now wearing ...
Novo, which has 78,400 positions globally, said about 5,000 of the job cuts will be in its native Denmark. Read more at ...
There are fears Denmark is facing a so-called “Nokia risk”. Read more at straitstimes.com. Read more at straitstimes.com.
The struggling Danish company says it looks to reorganize, with the impact on North Carolina workers still unclear.
FRANKFURT, Germany (AP) — Danish pharmaceutical company Novo Nordisk, maker of weight-loss drug Wegovy, said Wednesday it ...
3h
Mediafeed on MSNOzempic vs Metformin for weight loss: Weighing the pros & cons of each
Ozempic vs Metformin The increasing popularity of weight loss drugs like Wegovy®, Ozempic, Mounjaro and metformin may have ...
20h
Yen on MSNOzempic maker Novo Nordisk to cut 9,000 global jobs
COPENHAGEN: Danish pharmaceutical giant Novo Nordisk announced on Wednesday (Sep 10) that it would cut 11 per cent of its ...
The Danish pharma giant outlined proposals to shed around 11% of its 78,400-strong workforce amid stiff competition from ...
Novo Nordisk will cut 9,000 jobs, about 11.5% of its global workforce, as new CEO Maziar Mike Doustdar launches a major ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results